Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer. 2006 Sep 04; 95(5):581-6.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Benzenesulfonates
DNA Primers
Female
Genes, ras
Humans
Male
Melanoma
Middle Aged
Neoplasm Staging
Niacinamide
Phenylurea Compounds
Polymerase Chain Reaction
Proto-Oncogene Proteins B-raf
Pyridines
Safety
authors with profiles
Mark J. Ratain